Kimberly Trant, RN, MBA

Kimberly Trant, RN, MBA has over 20 years of work experience in various roles within the healthcare industry. Their most recent position is as the Executive Director and Head of Patient Advocacy at Neurogene Inc., where they started in September 2021. Prior to that, they held roles at Audentes Therapeutics, starting as the Director of Patient Advocacy and Engagement in May 2017 and progressing to the role of Executive Director. Kimberly also worked at Ultragenyx Pharmaceutical Inc. as an Associate Director of Patient Advocacy, Medical Affairs from August 2015 to April 2017.

Before joining Audentes Therapeutics and Ultragenyx Pharmaceutical Inc., Kimberly worked at Genentech as a Marketing-Group Manager, responsible for patient and healthcare provider (HCP) strategy and engagement in the Multiple Sclerosis and Transplant groups from June 2010 to August 2015. Prior to that, they were at GSK, where they held various positions, including Marketing-Neuroscience Senior Manager, Manager of Sales Analytics, and Specialty Sales Representative in the fields of neurology and psychiatry.

Their early career included a role as a Specialty Sales Representative at Merck from June 2001 to January 2004 and as an RN Case Manager at Health international from January 2000 to June 2001. Kimberly began their healthcare career as an RN in various departments at a hospital, including Med/Surg, Neonatal Nursery, and Pediatrics, from January 1997 to January 2000. Throughout their career, Kimberly Trant has demonstrated a strong commitment to patient advocacy and engagement.

Kimberly Trant, RN, MBA obtained their Bachelor of Science in Nursing from Arizona State University in 1998, specializing in Registered Nursing/Registered Nurse. Kimberly then pursued further education and completed their Master of Business Administration (MBA) from Keller Graduate School of Management in 2003.